This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eyenovia, Inc. (NASDAQ: EYEN) ("Eyenovia" or the "Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet ...

(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...

Qsic, the global intelligent in-store audio platform that elevates the in-store experience and drives incremental revenue, ...

On Monday, Eyenovia Inc (EYEN) stock saw a modest uptick, ending the day at $0.06 which represents no change from the prior close of of $0.06. The stock opened at $ and touched a low of $ during the ...

EYEN Stock Performance and Moving Averages. In recent trading, Eyenovia Inc (EYEN) stock price has shown some volatility, fluctuating -13.48% over the last five trades and -33.06% ...

Inc., a pharmaceutical company specializing in preparations, voted in favor of a reverse stock split and an increase in stock reserves for incentive plans, according to a filing with the Securities ...

DelveInsight's“Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the ...

Eyenovia (NASDAQ:EYEN), Inc., a pharmaceutical company specializing in preparations, has entered into a significant agreement that has led to the exercise of existing warrants and the expected ...

Virtual meeting scheduled for 10:00 a.m. ET on January 21st; stockholders must pre-register by 11:59 p.m. ET on January 20thNEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ ...

Eyenovia, Inc. announced on January 15, 2025, that leading proxy advisory firms ISS and Glass Lewis have advised stockholders to vote in favor of a proposed reverse stock split at a ratio between ...